Priunta (Trastuzumab) Injection
Salt Name: Trastuzumab Brand Name – Priunta Injection is available in India. Priunta 440 Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It contains the active substance Trastuzumab. Priunta is a prescription medication that must be administered in your doctor’s office. Trastuzumab (Brand name Priunta) is available in India. Brand Name Priunta Generic Name Trastuzumab Strength Injection 150 mg Manufacturer Abbott India Buy 100% authentic medicines from Aark Pharmaceuticals. Top CFA & pharma distributor supplying hospitals, clinics & patients across India. * Get the best price & exclusive discounts on Priunta Powder today! Call/WhatsApp Aark Pharmaceuticals at 9999156233 (Ms.Himansh), 9871948310 (Mr.Dheeraj) for instant availability
About Priunta (Trastuzumab) Injection
Description Is Trastuzumab Injection available in India? Yes, Trastuzumab Injection is available in India . It is marketed under the brand name Priunta among others. It is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer. It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel). The new indications are: HER2-Low Metastatic Breast Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with unresectable or metastatic HER2-Low breast cancer who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy. Locally Advanced or Metastatic Gastric Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab based regimen. Trastuzumab deruxtecan was earlier approved by Drug Controller General of India (DCGI), for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen. Approved in May 2023 for the treatment of metastatic breast cancer. In March 2024, the Central Drugs Standard Control Organisation (CDSCO) approved the drug for two additional indications: HER2-low metastatic breast cancer and HER2-positive gastric cancer. Who is the CFA, distributor, and retailer for Priunta (Trastuzumab) Injection in India? Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Priunta (Trastuzumab) Injections in India. It is marketed by Abbott. Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Abbott products, including advanced cancer treatments. The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup. How much do Priunta Injection cost in Delhi, India? Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals Seller Name: Aark Pharmaceuticals Private Limited. Contact P
